Medicare Enrolled
Dr. Carlos Pulido, MD
Anesthesiology · Athens, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pulido from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pulido?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pulido
Dr. Carlos Pulido is an anesthesiology specialist in Athens, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pulido performed 1,623 Medicare services across 1,117 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pulido received a total of $5,131 from 36 pharmaceutical and/or device companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pulido is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in GA
$5,131 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,623
Medicare services
Top 6% in GA for anesthesiology
1,117
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
625 | $60 | $279 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
110 | $12 | $45 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
96 | $75 | $327 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
88 | $109 | $350 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
66 | $46 | $185 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
51 | $34 | $140 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
49 | $102 | $943 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
49 | $96 | $556 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
48 | $55 | $305 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
46 | $195 | $600 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
42 | $75 | $518 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
34 | $61 | $600 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $82 | $323 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
32 | $151 | $500 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
30 | $198 | $1,500 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
29 | $102 | $810 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
28 | $77 | $710 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
28 | $58 | $391 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
25 | $69 | $695 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
25 | $40 | $418 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
23 | $30 | $183 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
23 | $17 | $243 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
16 | $66 | $572 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
14 | $189 | $1,261 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $121 | $497 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,131
Total received (2018-2024)
Avg $733/year across 7 years
Top 6% in GA for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,131 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$879
2023
$376
2022
$222
2021
$200
2020
$372
2019
$587
2018
$2,495
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$543
Stryker Corporation
$150
Boston Scientific Corporation
$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56
Collegium Pharmaceutical, Inc.
$34
SCILEX PHARMACEUTICALS INC.
$23
Curonix LLC
$16
Top 3 companies account for 85.3% of 2024 payments
All-time payments by company (2018-2024) ›
Vertiflex, Inc.
$1,207
Medtronic, Inc.
$653
Nevro Corp.
$390
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$329
Stimwave Technologies Incorporated
$284
BioDelivery Sciences International, Inc.
$272
Medtronic USA, Inc.
$245
Stryker Corporation
$150
Vertos Medical, Inc.
$137
Amgen Inc.
$135
Novartis Pharmaceuticals Corporation
$131
Nalu Medical, Inc.
$125
Neurelis, Inc.
$119
Scilex Pharmaceuticals Inc.
$109
Collegium Pharmaceutical, Inc.
$95
Boston Scientific Corporation
$81
Teva Pharmaceuticals USA, Inc.
$76
Abbott Laboratories
$69
Horizon Therapeutics plc
$57
Daiichi Sankyo Inc.
$51
Kaleo, Inc.
$44
Nuvectra Corporation
$42
FIDIA PHARMA USA INC.
$42
Biohaven Pharmaceutical Holding Company Ltd.
$39
Horizon Pharma plc
$34
Curonix LLC
$30
Takeda Pharmaceuticals U.S.A., Inc.
$29
SCILEX PHARMACEUTICALS INC.
$23
PFIZER INC.
$22
Egalet US Inc
$21
ARBOR PHARMACEUTICALS, INC.
$20
BOSTON SCIENTIFIC CORPORATION
$17
AbbVie Inc.
$16
Assertio Therapeutics, Inc.
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Purdue Pharma L.P.
$11
Top 3 companies account for 43.8% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · Algovita · Amitiza · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · Cambia · DUEXIS · ETERNA · EVZIO · Evzio · GENERAL PAIN MANAGEMENT · Gralise · HYALGAN · Horizant · INTELLIS ADAPTIVESTIM · LYRICA · MILD DEVICE KIT · Morphabond ER · N'VISION · NURTEC ODT · Nalu Neurostimulation System · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · RELISTOR · RELISTOR ORAL · RESTORE · SPECTRA WAVEWRITER · SPRIX · SYMPROIC · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion ISS · Superion Indirect Decompression System · UBRELVY · VALTOCO · XTAMPZA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for anesthesiology in GA.
Geographic Context
Anesthesiologists within 10 mi
35
Per 100K population
27.1
County median income
$52,267
Nearest hospital
ST MARY'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pulido is a clinical cardiology specialist, with above-average Medicare volume (top 6% in GA), with low-engagement industry engagement in the top 6% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pulido experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Pulido performed 625 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pulido receive payments from pharmaceutical companies?
Yes. Dr. Pulido received a total of $5,131 from 36 companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pulido's costs compare to other anesthesiologists in Athens?
Dr. Pulido's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pulido) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Athens
Browse anesthesiologists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in GA
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in GA
Which GA anesthesiologists receive the most from drug and device companies.
By company
Vertiflex, Inc. Payments to Doctors
See all physicians who received payments from Vertiflex, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology